We are live on ! Find out more
COYA icon

Coya Therapeutics

58 hedge funds and large institutions have $46M invested in Coya Therapeutics in 2025 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 19 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 4

314% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 7

70% more capital invested

Capital invested by funds: $27.1M → $46M (+$18.9M)

61% more funds holding

Funds holding: 3658 (+22)

9.51% more ownership

Funds ownership: 28.44%37.94% (+9.5%)

Holders
58
Holders Change
+22
Holders Change %
+61.11%
% of All Funds
0.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
19
Reduced
4
Closed
7
Calls
$56K
Puts
Net Calls
+$56K
Net Calls Change
+$56K
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
1
DME Capital Management
New York
$11.8M +$2.31M +379,500 +23%
ACM
2
AIGH Capital Management
Maryland
$5.66M -$792K -130,218 -12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.22M +$381K +62,747 +8%
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$4.64M +$4.86M +800,000 New
AIC
5
AWM Investment Company
New York
$4.21M +$4.41M +725,000 New
CM
6
CM Management
Florida
$2.03M +$304K +50,000 +17%
PMG
7
Private Management Group
California
$1.63M +$1.7M +280,267 New
Marshall Wace
8
Marshall Wace
United Kingdom
$1.31M +$1.12M +183,533 +439%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.15M +$250K +41,143 +26%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$724K +$556K +91,476 +274%
JC
11
JBF Capital
Colorado
$580K +$608K +100,006 New
6CM
12
683 Capital Management
New York
$465K +$487K +80,128 New
BlackRock
13
BlackRock
New York
$459K +$55.9K +9,188 +13%
State Street
14
State Street
Massachusetts
$403K +$130K +21,410 +45%
Renaissance Technologies
15
Renaissance Technologies
New York
$388K +$195K +32,100 +92%
Squarepoint
16
Squarepoint
New York
$378K +$396K +65,150 New
Point72 Asset Management
17
Point72 Asset Management
Connecticut
$357K +$374K +61,584 New
Morgan Stanley
18
Morgan Stanley
New York
$309K +$315K +51,831 +3,399%
PCM
19
Prelude Capital Management
New York
$303K +$100K +16,500 +46%
Northern Trust
20
Northern Trust
Illinois
$234K +$49.2K +8,097 +25%
Bank of America
21
Bank of America
North Carolina
$231K +$241K +39,569 +18,404%
LCAM
22
Long Corridor Asset Management
Hong Kong
$225K +$236K +38,766 New
Walleye Capital
23
Walleye Capital
New York
$215K +$225K +37,062 New
WHG
24
Westwood Holdings Group
Texas
$213K +$223K +36,660 New
UBS Group
25
UBS Group
Switzerland
$203K +$132K +21,737 +163%

COYA Hedge Fund Activity: Q4 2025 in Review

58 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q4 2025, worth a combined $46M — up 70% from $27.1M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new COYA positions and 7 closed out — a net gain of 22 holders — while 19 added to existing stakes and 4 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $4.86M. The largest seller was Dauntless Investment Group, exiting entirely with an estimated $872K sold.

  • 58 institutional investors held Coya Therapeutics (COYA) as of Q4 2025, up from 36 in Q3 2025.
  • Funds reported $46M of Coya Therapeutics stock for Q4 2025, up 70% quarter-over-quarter.
  • 29 funds opened new Coya Therapeutics positions in Q4 2025 and 7 closed out, a net change of +22 holders.
  • The largest Coya Therapeutics buyer in Q4 2025 was Alyeska Investment Group, an estimated $4.86M added.
  • The largest Coya Therapeutics seller in Q4 2025 was Dauntless Investment Group, an estimated $872K sold.

Based on aggregated 13F filings for Q4 2025.